Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › ORKA

SILVERARC CAPITAL MANAGEMENT, LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 247,918 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$20.6M, representing 2.63% of its reported portfolio and ranking #12 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ORKA holdings in 4 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)247.92K sh
Reported value held$20.65M
Portfolio Weight2.63%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's ORKA position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in ORKA in Q2 2025 at 165,389 shares (US$1.9M). The position peaked in Q2 2026 at 352,802 shares, worth US$33.6M. Across 4 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 247,918 shares valued at US$20.6M — a reduction of -104,884 shares quarter over quarter.. Notable position changes include a 134% increase in Q2 2026 (shares fell 12% over the following quarter), a 30% trim in Q3 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 165.39K $1.85M New
Q1 2026 150.91K $7.40M New
Q2 2026 352.80K $33.58M Add
Q3 2026 247.92K $20.65M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 87 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held ORKA?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ORKA holdings in 4 of the last 6 reported quarters, going back to Q2 2025.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ORKA?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 247.92K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $20.65M, representing 2.63% of its reported portfolio and ranking #12.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ORKA?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC reduced its position in ORKA. The position peaked in Q2 2026 at 352.80K shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 87 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.